Omega Healthcare Investors - OHI Stock Forecast, Price & News

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Omega Healthcare Investors in the last year. There are currently 1 sell rating, 7 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" OHI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OHI, but not buy additional shares or sell existing shares.
View OHI analyst ratings or view top-rated stocks.

9 Wall Street research analysts have issued 1 year price targets for Omega Healthcare Investors' shares. Their OHI share price forecasts range from $25.00 to $34.00. On average, they predict the company's share price to reach $30.22 in the next twelve months. This suggests a possible upside of 10.9% from the stock's current price.
View analysts price targets for OHI or view top-rated stocks among Wall Street analysts.

Omega Healthcare Investors' stock was trading at $27.95 at the beginning of 2023. Since then, OHI stock has decreased by 2.5% and is now trading at $27.26.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023.
View our OHI earnings forecast.

Omega Healthcare Investors, Inc. (NYSE:OHI) posted its quarterly earnings data on Monday, August, 1st. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.73 by $0.35. The real estate investment trust earned $207.54 million during the quarter, compared to the consensus estimate of $220.06 million. Omega Healthcare Investors had a net margin of 48.61% and a trailing twelve-month return on equity of 10.83%. The business's revenue for the quarter was down 4.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.85 EPS.

Omega Healthcare Investors announced a quarterly dividend on Thursday, January 26th. Stockholders of record on Monday, February 6th will be given a dividend of $0.67 per share on Wednesday, February 15th. This represents a $2.68 annualized dividend and a dividend yield of 9.83%. The ex-dividend date is Friday, February 3rd.
Read our dividend analysis for OHI.

ETFs with the largest weight of Omega Healthcare Investors (NYSE:OHI) stock in their portfolio include BNY Mellon Global Infrastructure Income ETF (BKGI), Invesco KBW Premium Yield Equity REIT ETF (KBWY), Global X SuperDividend REIT ETF (SRET), ALPS REIT Dividend Dogs ETF (RDOG), iShares Residential and Multisector Real Estate ETF (REZ), Fidelity Stocks For Inflation ETF (FCPI), Global X SuperDividend ETF (SDIV) and Hoya Capital High Dividend Yield ETF (RIET).

Omega Healthcare Investors (NYSE:OHI) pays an annual dividend of $2.68 per share and currently has a dividend yield of 9.91%. OHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 149.72%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, OHI will have a dividend payout ratio of 96.06% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for OHI.

3 employees have rated Omega Healthcare Investors Chief Executive Officer C. Taylor Pickett on Glassdoor.com. C. Taylor Pickett has an approval rating of 56% among the company's employees. This puts C. Taylor Pickett in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Omega Healthcare Investors investors own include AT&T (T), Enterprise Products Partners (EPD), Verizon Communications (VZ), Energy Transfer (ET), Realty Income (O), Cisco Systems (CSCO), AbbVie (ABBV), Annaly Capital Management (NLY), New Residential Investment (NRZ) and Pfizer (PFE).

Omega Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "OHI."

Omega Healthcare Investors' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (1.80%), Edmp Inc. (1.62%), Dimensional Fund Advisors LP (1.37%), LSV Asset Management (1.28%), Charles Schwab Investment Management Inc. (1.08%) and Morgan Stanley (0.98%). Insiders that own company stock include Burke W Whitman, Burke W Whitman, C Taylor Pickett, Daniel J Booth, Kapila K Anand, Michael Ritz, Neal Ballew, Robert O Stephenson and Steven J Insoft.
View institutional ownership trends.

Shares of OHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OHI stock can currently be purchased for approximately $27.26.

Omega Healthcare Investors (NYSE:OHI) has a market capitalization of $6.39 billion and generates $878.24 million in revenue each year. The real estate investment trust earns $426.93 million in net income (profit) each year or $1.79 on an earnings per share basis.

Omega Healthcare Investors' mailing address is 303 International Circle Suite 200, HUNT VALLEY MD, 21030. The official website for the company is www.omegahealthcare.com. The real estate investment trust can be reached via phone at (410) 427-1700, via email at mgourmand@omegahealthcare.com, or via fax at 410-427-8800.